METTL14 and cancer: Previous studies have shown that METTL14 regulates autophagy in cancer cells (Kong et al., 2020; F. Wang et al., 2021) and inhibited autophagy and stimulates apoptosis and inflammation in injured podocytes by promoting Sirt1 mRNA degradation via m6A modification (Lu et al., 2021).